Coalition Resection and Extra‐Osseous Talotarsal Stabilization for Talocalcaneal Coalition With Pes Planus Deformity: A Retrospective Study
Orthopaedic Surgery · 2025
DOI: 10.1111/os.70151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Orthopaedic Surgery, 2025. Verfasst von Wenqi Gu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Flatfoot, Tarsal Coalition, Talus, Calcaneus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Commission of Economy and Informatization.
Abstract (Originalsprache)
Objective
The treatment of talocalcaneal coalition (TCC) with pes planus deformity in adolescent patients still presents challenges. With the pes planus deformity untreated, the final clinical outcome would be compromised. Therefore, simultaneous correction of pes planus deformity seems to be of great importance. This study aimed to retrospectively evaluate the clinical efficacy of coalition resection combined with extra‐osseous talotarsal stabilization (EOTTS) treatment for adolescent TCC with pes planus deformity.
Methods
Data was reviewed for patients of TCC and pes planus deformity treated by coalition resection and EOTTS from January 2018 to January 2024. Meary's angle and talar‐1st metatarsal angle (T1MA) were measured to assess the alignment improvement (paired sample t ‐test). Visual analog scale (VAS) for pain (Wilcoxon signed rank test) and American Orthopedic Foot & Ankle Society ankle‐hindfoot score (AOFAS‐AHS) (paired sample t ‐test) were evaluated for the overall clinical outcomes. Time to return to sports activity and complications were also recorded.
Results
No early wound or soft tissue complications occurred. At 1‐year follow‐up, Meary's angle and T1MA improved from 13.4° ± 5.2° to 5.1° ± 3.4°, and from 14.7° ± 3.7° to 6.4° ± 2.5°, respectively. The median VAS score decreased from 5 to 0, while the AOFAS‐AHS increased from 51.1 ± 8.9 to 90.1 ± 9.3 (all p < 0.05). Fifteen patients returned to sports at a median of 3 months (range: 2–4 months). One patient experienced sinus tarsi pain, which was resolved after implant removal at 14th month postoperatively.
Conclusion
Simultaneous coalition resection and EOTTS for adolescent TCC with pes planus deformity achieves satisfactory clinical outcomes with minimal complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
- Department of Orthopaedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Trauma Orthopaedics, Weifang Hospital of Traditional Chinese Medicine, Weifang, Shandong, China.
ORCID-Profile: Shaoling Fu, Hongtao Zhang
Förderung
- Science and Technology Commission of Shanghai Municipality
- Shanghai Municipal Commission of Economy and Informatization
Zitieren
APA
Gu, W., Xu, X., Fu, S., Song, G., Shi, Z., & Zhang, H. (2025). Coalition Resection and Extra‐Osseous Talotarsal Stabilization for Talocalcaneal Coalition With Pes Planus Deformity: A Retrospective Study. Orthopaedic Surgery. https://doi.org/10.1111/os.70151
Vancouver
Gu W, Xu X, Fu S, Song G, Shi Z, Zhang H. Coalition Resection and Extra‐Osseous Talotarsal Stabilization for Talocalcaneal Coalition With Pes Planus Deformity: A Retrospective Study. Orthopaedic Surgery. 2025. doi:10.1111/os.70151
BibTeX
@article{Gu2025,
author = {Gu, Wenqi and Xu, Xianchao and Fu, Shaoling and Song, Guoxun and Shi, Zhongmin and Zhang, Hongtao},
title = {Coalition Resection and Extra‐Osseous Talotarsal Stabilization for Talocalcaneal Coalition With Pes Planus Deformity: A Retrospective Study},
journal = {Orthopaedic Surgery},
year = {2025},
doi = {10.1111/os.70151}
}
EUVIMED